By Counterforce Health Team in Chenodal (chenodiol) —

How to Get Chenodal (chenodiol) Covered by Blue Cross Blue Shield in Washington: Complete PA Guide with Appeals Process

Answer Box: Quick Path to Approval

To get Chenodal (chenodiol) covered by Blue Cross Blue Shield in Washington: Submit prior authorization with imaging confirming radiolucent gallstones, documentation of surgical ineligibility, and proof of ursodiol failure/intolerance for ≥6 months. If denied, you have 60-120 days to request external review through an Independent Review Organization (IRO). Start by calling your BCBS plan's member services number on your insurance card to request PA forms.

First step today: Download PA forms from your BCBS provider portal or call member services to confirm Chenodal's formulary status and specific requirements.

Table of Contents

  1. Policy Overview: How BCBS Handles Chenodal Coverage
  2. Medical Necessity Requirements
  3. Step Therapy and Exception Pathways
  4. Required Diagnostics and Documentation
  5. Site of Care and Specialty Pharmacy Rules
  6. Appeals Process in Washington
  7. Common Denial Reasons and Solutions
  8. Cost-Saving Options
  9. FAQ
  10. Sources and Further Reading

Policy Overview: How BCBS Handles Chenodal Coverage

Blue Cross Blue Shield plans in Washington—including Premera Blue Cross and Regence BlueShield—typically classify Chenodal (chenodiol) as a specialty medication requiring prior authorization. The drug dissolves radiolucent cholesterol gallstones in patients who cannot undergo surgery.

Key Plan Types and Coverage:

  • Commercial Plans: Standard PA process through provider portals
  • Medicare Advantage: May follow Medicare Part D guidelines with additional plan-specific criteria
  • Medicaid (Apple Health): Covered with medical necessity documentation

Most Washington BCBS plans use formulary management through pharmacy benefit managers like Prime Therapeutics or CVS Caremark. Verify your specific plan's formulary and PA requirements through your member portal.

Note: Starting January 2026, Premera and other BCBS plans will reduce PA burden with 90-day prior approval honors when switching plans and electronic submission targets by 2027.

Medical Necessity Requirements

Chenodal approval requires meeting specific clinical criteria that align with FDA labeling and payer policies. Based on major insurer requirements, here's what BCBS typically expects:

Coverage Criteria Table

Requirement What It Means Documentation Needed
Age ≥18 years Date of birth verification
Stone Type Radiolucent (cholesterol-based) stones only Ultrasound or imaging confirming non-calcified stones
Gallbladder Function Well-opacifying gallbladder Oral cholecystogram or equivalent imaging
Surgical Ineligibility Cannot undergo cholecystectomy Provider attestation with medical justification
Prior Therapy Ursodiol failure/intolerance ≥6 months Treatment records, response documentation
Specialist Involvement Gastroenterologist consultation Referral or specialist prescription
Duration Limits Typically 12-24 months lifetime maximum Treatment timeline documentation

Medical Necessity Justification

Your provider's letter should address these points:

  • Diagnosis: ICD-10 codes (e.g., K80.20 for calculus of gallbladder without obstruction)
  • Symptom Impact: How gallstones affect quality of life (biliary colic, pain episodes)
  • Imaging Evidence: Ultrasound confirming radiolucent stones <15-20mm diameter
  • Surgical Risk: Age, comorbidities, or conditions making surgery high-risk
  • Treatment Goals: Stone dissolution, symptom relief, surgical avoidance

Step Therapy and Exception Pathways

Most BCBS plans require trying ursodiol (ursodeoxycholic acid) before approving Chenodal. This "step therapy" can be bypassed with proper documentation.

Exception Criteria

Automatic Approval Scenarios:

  • Documented ursodiol allergy or severe intolerance
  • FDA contraindication to ursodiol
  • Ineffective response after ≥6 months of adequate dosing
  • Current stable ursodiol use with provider preference for Chenodal

Documentation Requirements:

  • Treatment dates and dosages tried
  • Specific side effects or lack of efficacy
  • Clinical notes showing symptoms persistence
  • Laboratory values if relevant (liver function tests)
Tip: BCBS plans are streamlining step therapy exceptions with faster processing for well-documented cases.

Required Diagnostics and Documentation

Successful Chenodal approval requires specific imaging and laboratory evidence:

Essential Diagnostics

Imaging Requirements:

  • Ultrasound: Confirming gallstone presence and radiolucent characteristics
  • Oral Cholecystogram: Demonstrating well-opacifying gallbladder (may be required)
  • CT Scan: If available, showing non-calcified stone composition

Laboratory Values:

  • Liver Function Tests: Baseline ALT, AST, bilirubin (normal values required)
  • Complete Blood Count: Baseline values for monitoring
  • Lipid Panel: May be requested to assess cholesterol metabolism

Documentation Timeline

All imaging should be recent (typically within 6-12 months) and laboratory values current (within 3-6 months). Older studies may require updating before PA approval.

Site of Care and Specialty Pharmacy Rules

BCBS plans often have specific dispensing requirements for Chenodal:

Pharmacy Network Requirements:

  • May require specialty pharmacy dispensing
  • Some plans limit to specific networks (CVS Specialty, Express Scripts)
  • Retail pharmacy may not be covered for this medication

Administration Details:

  • Oral medication taken at home
  • No infusion or injection site restrictions
  • Regular monitoring through outpatient visits

Contact your plan to verify covered pharmacies before the prescription is written.

Appeals Process in Washington

Washington state provides strong consumer protections for insurance appeals, including external review through Independent Review Organizations (IROs).

Step-by-Step Appeals Process

1. Internal Appeal (First Level)

  • Timeline: File within 60-120 days of denial (varies by plan)
  • Method: Submit via BCBS appeals department using denial letter instructions
  • Documentation: Include all medical records, imaging, treatment history
  • Decision: Typically within 30 days for non-urgent cases

2. External Review (IRO)

  • Eligibility: After unfavorable internal appeal decision
  • Timeline: Request within 60 days of final internal denial
  • Process: BCBS assigns certified IRO; decision in 20 days (standard) or 72 hours (expedited)
  • Cost: No fee to patient; insurer pays IRO costs

3. Washington Insurance Commissioner Complaint

Required Appeal Documents

  • Original denial letter
  • Complete medical records
  • Imaging reports and films
  • Provider medical necessity letter
  • Treatment timeline documentation
  • Any new supporting evidence
From our advocates: We've seen Washington patients successfully overturn BCBS denials by focusing on the surgical ineligibility documentation. One composite case involved a 78-year-old with multiple comorbidities where the external review IRO overturned the denial based on detailed cardiac risk assessment that the internal reviewers had initially overlooked.

Common Denial Reasons and Solutions

Denial Reason Solution Strategy Required Documentation
"Not medically necessary" Submit comprehensive medical necessity letter Symptom diary, quality of life impact, specialist consultation
"Step therapy not completed" Document ursodiol trial failure Prescription records, side effect documentation, treatment timeline
"Experimental/investigational" Cite FDA approval and compendia FDA label, peer-reviewed studies, guideline recommendations
"Surgical option available" Provide surgical risk assessment Cardiology clearance, anesthesia consultation, comorbidity documentation
"Imaging inadequate" Submit required radiology studies Recent ultrasound, oral cholecystogram if requested

Peer-to-Peer Review Strategy

If initially denied, request a peer-to-peer review where your gastroenterologist speaks directly with the BCBS medical director. Prepare talking points about:

  • Patient's specific clinical situation
  • Why surgery isn't appropriate
  • Evidence supporting Chenodal efficacy
  • Monitoring plan for safety

Cost-Saving Options

Manufacturer Support:

  • Travere Therapeutics may offer patient assistance programs
  • Check manufacturer website for current copay card availability
  • Income-based assistance for eligible patients

Insurance Optimization:

  • Verify formulary tier (Tier 3/4 specialty typically)
  • Consider generic alternatives if available
  • Review plan's specialty pharmacy copay structure

State Resources:

  • Washington State Pharmaceutical Assistance Program (verify eligibility)
  • Apple Health (Medicaid) coverage if income-qualified

FAQ

How long does BCBS prior authorization take in Washington? Standard PA decisions typically take 3-5 business days. Expedited reviews (for urgent cases) are processed within 72 hours. Premera commits to faster processing starting in 2026.

What if Chenodal isn't on my BCBS formulary? Request a formulary exception with medical necessity documentation. Plans must consider non-formulary drugs when medically necessary and no covered alternatives are appropriate.

Can I get expedited appeal if my symptoms are severe? Yes, if your condition could seriously jeopardize your health without treatment. Submit expedited appeal request with provider documentation of urgency.

Does step therapy apply if I tried ursodiol outside Washington? Yes, treatment history from other states counts toward step therapy requirements. Provide complete medical records showing the trial and outcome.

What happens if the IRO denies my appeal? The IRO decision is binding on your insurer, but you can still file a complaint with the Washington Insurance Commissioner or consult legal options for ERISA plans.

How much does Chenodal cost without insurance? Brand-name pricing varies by strength and pharmacy. Contact Travere Therapeutics for current pricing and patient assistance program availability.

Getting insurance approval for specialty medications like Chenodal can be complex, but you don't have to navigate it alone. Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters, identifies the specific denial basis, and drafts point-by-point rebuttals aligned with your plan's own rules, pulling the right citations and clinical evidence to support your case.

When dealing with BCBS denials in Washington, having the right documentation and appeal strategy can make the difference between paying thousands out-of-pocket or getting your medication covered. The state's strong external review process gives you additional leverage, but success often depends on presenting your case with the clinical evidence and procedural knowledge that Counterforce Health's platform provides.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies vary by plan and region. Always verify current requirements with your specific BCBS plan and consult healthcare providers for medical decisions. For personalized assistance with appeals, contact the Washington Office of Insurance Commissioner or consider professional advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.